-Hindustan Times The government is set to re-launch its pharmacy chain, Jan Aushadhi, to sell generic drugs ranging from anti-biotics, anti-cardiac, anti-infective and gastro intestinal drugs at prices at least half of branded drugs. The project would be launched in six states on a pilot basis from June 21, where 5,000 stores would be opened across the country in a phased manner. The scheme failed in 2008 due to poor supply-chain management. “Now, we...
More »SEARCH RESULT
TB, diabetes drug prices to fall by 30% -Sushmi Dey
-The Times of India NEW DELHI: The drug price regulator has capped prices of 30 medicines including antibiotics and those used in treatment of diabetes, tuberculosis and malaria. The move is expected to bring down prices of most of these medicines by 25-30%. However, in some cases the reduction could be by as much as 50%. The National Pharmaceutical Pricing Authority (NPPA), which has the mandate to regulate Prices of essential medicines,...
More »Jan Aushadhi: in need of a right prescription -PT Jyothi Datta
-The Hindu Business Line Generic prescription patterns, supply-chain management must for low-cost drug availability An earnest-sounding voice answers the Jan Aushadhi hotline number and assures the person calling that more stores are being planned by the Government in districts across the country. That response was to the caller’s query if there was a Jan Aushadhi (JA) store in Mumbai. As it happens, there is one in Maharashtra, but in Pune! It’s been over...
More »Chemists will have to mention in bill whether drug is price controlled -Sushmi Dey
-The Times of India NEW DELHI: In an attempt to empower consumers and save them from paying more for medicines, the government is set to make it mandatory for chemists to mention in the bill whether they are selling a price-controlled product or not. Besides, the bill will also mention the price of the medicine as capped by the government. The move will enable a consumer to make an informed choice while...
More »Govt may negotiate price of drugs before market entry -Sushmi Dey
-The Times of India NEW DELHI: The government may negotiate prices of patented medicines with their manufacturers before allowing pharmaceutical companies to launch them in India. The move, a first of its kind, is also likely to be applied on patented drugs that are already being sold in the country, an official source said. An inter-ministerial committee, evaluating the mechanism to negotiate prices of patented medicines, has recently sought detailed information about...
More »